Scientific Programme

Thursday, January 30, 2025

Opening                                 

Time Presentation Title Speaker
08:30-08:45
 Opening & Objectives
Paola Anna Erba
Sofia Carrilho Vaz
Karolien Goffin

 

Thursday, January 30, 2025

Assessing Suspicious Breast Lesions with Imaging (T&N Staging)

Chairpersons: Isabel T. Rubio, Elizabeth Dibble, Thiemo van Nijnatten

Time Presentation Title Speaker
08:47-09:05 Essential Information Needed for Clinical Decision Isabel T. Rubio
09:08-09:26 State of the Art in Pathology Frederique Penault-Llorca
09:29-09:47 Optimal Diagnosis of Breast Cancer with Radiologic Imaging (T & N Staging) Thiemo van Nijnatten
09:50-10:08 Indications for Molecular Breast Imaging (Scintigraphy and PET) Elizabeth Dibble
10:11-10:29
Expectations from Lymphoscintigraphy and Imaging-Guided Surgery
Tessa Buckle
11:00-11:15 Controversy: How to Position Molecular Imaging in Evaluating Breast Lesions?  Tessa Buckle
11:16-11:23
In Favour
Elizabeth Dibble
11:24-11:31
Against
Katja Pinker Domenig
11:32-11:47 The Surgeon’s Perspective Isabel T. Rubio
11:48-11:58
Questions & Answers
All
12:00-13:00
Consensus on Imaging for Suspicious Breast Lesions (T&N Staging)
Sofia Carrilho Vaz

 

Thursday, January 30, 2025

Baseline Systemic Staging of Breast Cancer (M Staging) 

Chairpersons: Alessandra Gennari, David Groheux, Katja Pinker Domenig

Time Presentation Title Speaker
14:00-14:20 How Can Conventional Imaging Help in Clinical Decision Martina Bašić Koretić
14:21-14:41 Indications for PET with FDG David Groheux
14:42-15:02 Indications for PET with FES Gary Ulaner
15:03-15:18 Molecular Characterisation with wbMRI (Special Clinical Needs & Bone Assessment) Katja Pinker Domenig
15:19-15:35 
‘In Vivo’ Molecular Characterisation Using PET
Geraldine Gebhart
16:00-16:15 Controversy: Is it Time to Include Tumour-Specific Tracers in Breast Cancer Staging? Wolfgang Weber
16:16-16:23
In Favour
Thiemo van Nijnatten
16:24-16:31
Against
Valeria Romeo
16:32-16:47
The Oncologist’s Perspective
Alessandra Gennari
16:48-16:58
Questions & Answers 
All
17:00-18:00
Consensus on Imaging for Baseline Systemic Staging of Breast Cancer (M Staging) 
Karolien Goffin

 

Friday, January 31, 2025

Assessing Systemic Treatment Response with Imaging

Chairpersons: Nadia Harbeck, Gary Cook, Pascal Baltzer

Time Presentation Title Speaker
09:00-09:18 Clinical Assessment of Treatment Response in Early Breast Cancer Nadia Harbeck
09:20-09:38 Imagiological Assessment of Treatment Response in Early Breast Cancer Pascal Baltzer
09:40-09:58 Clinical Assessment of Treatment Response in Advanced Breast Cancer Michel van Kruchten
10:00-10:18 Radiological Criteria to Assess Treatment Response in Advanced Breast Cancer   Valeria Romeo
10:20-10:35 PET in Assessing Treatment Response in Advanced Breast Cancer     Gary Cook
11:00-11:15 Controversy: Is FDG PET/CT Ready to Assess Therapy Response? Malene Hildebrandt
11:16-11:23 In Favour David Groheux
11:24-11:31 Against Thiemo van Nijnatten
11:32-11:47 The Oncologist’s Perspective Nadia Harbeck
11:48-12:58 Questions & Answers All
12:00-13:00 Consensus on Imaging for Assessing Systemic Treatment Response  Paola Anna Erba

 

Friday, January 31, 2025

Assessing Systemic Recurrence with Imaging

Chairpersons: Carolien Schröder, Malene Hildebrandt, Ritse Mann

Time Presentation Title Speaker
14:00-14:20 When to Suspect Tumour Recurrence Joana M Ribeiro
14:25-14:45 The Challenge of Oligometastatic Disease   Carolien Schröder
14:50-15:10  Assessing Recurrence with Conventional Imaging Ritse Mann
15:15-15:35 Assessing Recurrence with PET/CT and PET/MRI Thiemo van Nijnatten
16:00-16:15 Controversy: Is PET Ready to Assess Recurrence in All Breast Cancer Subtypes?   Philipp Backhaus
16:16-16:23
In Favour
Malene Hildebrandt
16:24-16:31 Against Pascal Baltzer
16:32-16:47 The Oncologist’s Perspective Carolien Schröder
16:48-16:58 Questions & Answers All
17:00-18:00 Consensus on Imaging for Assessing Breast Cancer Systemic Recurrence Fatima Cardoso

Saturday, February 1, 2025

Future Imaging Challenges & Developments in Breast Cancer

Chairpersons: Francesco Schettini, Gary Ulaner, Antoinette Attard

Time Presentation Title Speaker
09:00-09:15 Expectations Towards a More Patient-Centred Approach Antoinette Attard
09:17-09:35 The Most Promising New Biological Targets Francesco Schettini
09:37-09:55 New Targets Used in Radiopharmaceuticals Philipp Backhaus
09:57-10:15 Bone Pain Palliation & Theranostics Possibilities Karolien Goffin
10:17-10:35 Impact of PET-Based Radiation Therapy Planning Sofia Rivera
10:37-10:52 Controversy: What Is Still Needed to Move Theranostics Further in Breast Cancer? Gary Ulaner
11:15-12:15 Overall Consensus Sofia Carrilho Vaz
12:15-12:30 Consensus on ‘Relevant Factors to Build a Consensus’   Paola Anna Erba
12:30-12:50 Summary of Results and Debate with All Participants Fatima Cardoso
12:50-13:00 Future Directions & Closing Remarks Paola Anna Erba
Karolien Goffin